DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
LGD-3303 is an investigational drug.
There have been 9 clinical trials for LGD-3303. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2005.
The most common disease conditions in clinical trials are Diabetes Mellitus, Barrett Esophagus, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Ligand Pharmaceuticals, Medpace, Inc., and AstraZeneca.
Recent Clinical Trials for LGD-3303
|A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus||Ligand Pharmaceuticals||Phase 2|
|A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation||Medpace, Inc.||Phase 1|
|A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation||Ligand Pharmaceuticals||Phase 1|